InnoCare OptoelectronicsTPE:6861 -9.15%66 EBITDA Margin % is 13.68% as of Dec. 2025, which is 3% below its 10-year median of 14.10. GuruFocus rates TPE:6861 with a GF Score™ of 66/100 and a GF Value™ of NT$85.66 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, InnoCare Optoelectronics ranks better than 58.95% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
InnoCare Optoelectronics EBITDA Margin % Related Terms
InnoCare Optoelectronics EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6861 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, InnoCare Optoelectronics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnoCare Optoelectronics EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InnoCare Optoelectronics's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where InnoCare Optoelectronics's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnoCare Optoelectronics (TPE:6861) has a EBITDA Margin % of 13.68% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on InnoCare Optoelectronics and its competitors. This is near median its historical median of 14.10. Over the past decade, InnoCare Optoelectronics' EBITDA Margin % has ranged from 11.47 to 26.68. According to the industry distribution chart, InnoCare Optoelectronics ranks #335 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 41.1%.
Is InnoCare Optoelectronics' EBITDA Margin % too high?
InnoCare Optoelectronics' current EBITDA Margin % of 13.68% is near median its 10-year median of 14.10. Over the past 10 years, this metric has ranged from a low of 11.47 to a high of 26.68. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. InnoCare Optoelectronics' value of 13.68% is 83% above this industry median. Based on the distribution chart, InnoCare Optoelectronics ranks #335 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, InnoCare Optoelectronics has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnoCare Optoelectronics' EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, InnoCare Optoelectronics ranks #335 out of 816 companies for EBITDA Margin %. This puts InnoCare Optoelectronics in the upper half of its industry. The industry median EBITDA Margin % is 7.48. InnoCare Optoelectronics' value of 13.68% is 83% above this benchmark. Historically, InnoCare Optoelectronics' own EBITDA Margin % has ranged from 11.47 to 26.68 over the past decade. While the company's 10-year median is 14.10 vs. the industry median of 7.48, InnoCare Optoelectronics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnoCare Optoelectronics's current EBITDA Margin % of 13.68% is 83% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on InnoCare Optoelectronics and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnoCare Optoelectronics's current EBITDA Margin % is 13.68%, which is near median its own 10-year median of 14.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCare Optoelectronics stock overvalued right now?
Based on GuruFocus' analysis, InnoCare Optoelectronics (TPE:6861) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$85.66, compared to a current price of NT$303.00 — trading 253.7% above its estimated fair value. The current EBITDA Margin % is 13.68%, which is near median its 10-year median of 14.10 and 83% above the Medical Devices & Instruments industry median of 7.48. InnoCare Optoelectronics' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For InnoCare Optoelectronics (TPE:6861), the current EBITDA Margin % is 13.68% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnoCare Optoelectronics (TPE:6861) Overvalued in 2026?
Based on GuruFocus' analysis, InnoCare Optoelectronics stock appears to be overvalued.
The current stock price of NT$303.00 is trading 253.7% above its estimated GF Value™ of NT$85.66.
GuruFocus considers InnoCare Optoelectronics to be Significantly Overvalued.
Key valuation signals for TPE:6861:
EBITDA Margin %: 13.68% (near median its 10-year median of 14.10)
GF Value™: NT$85.66 vs. price of NT$303.00 (253.7% above fair value)
Industry Position: 83% above the Medical Devices & Instruments median (#335 of 816)
No single metric tells the full story. See the TPE:6861 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnoCare Optoelectronics Corp is mainly engaged in the manufacturing and sale of optical instruments and medical equipment. Its products include X-Ray flat panel detector devices, X-Ray flat panel detector modules, and others.
66GF Score
Get the complete analysis for TPE:6861
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6861 has been successfully added to your 
